Skip to main content
TOPICS
Videos
Podcasts
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
DreaMed Advisor Pro
FDA greenlights DreaMed's AI-backed insulin management tool for folks with Type 2 diabetes
By
Emily Olsen
|
12:12 pm |
October 07, 2021
The latest approval marks DreaMed’s fourth clearance from the Food and Drug Administration.
FDA grants DreaMed's de novo request for device-friendly diabetes software
By
Dave Muoio
|
09:52 am |
June 18, 2018